Developer docs
API playgroundTry for free, no card

Search company profiles

Theranostics

Full company profile

uuid002tkxx

Namestring
Theranostics
Legal namestring
Ivyspring International Publisher
Websiteurl
thno.org
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Theranostics is a peer-reviewed open access scientific journal publishing original research in in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher, a private entity domiciled in New South Wales, Australia, and reports an Impact Factor of 14.9. Full texts are archived in PubMed Central and Europe PMC, and the journal is indexed by the Science Citation Index (SCI) and MEDLINE, ensuring broad global discoverability and full compliance with the NIH Public Access Requirement. New articles are distributed under a Creative Commons Attribution 4.0 International (CC-BY) license, with earlier articles under CC-BY-NC 4.0.

The editorial platform is led by Founding Editor-in-Chief Prof. Xiaoyuan (Shawn) Chen (H-index 219, approximately 180,000 citations; Clarivate Highly Cited Researcher for eight consecutive years), whose scientific standing in nuclear medicine, molecular imaging, and nanomedicine anchors the journal's submission quality and reputation. The publisher operates a broader journal portfolio (Nanotheranostics, International Journal of Biological Sciences, International Journal of Medical Sciences, Journal of Cancer) that creates cross-referencing and shared infrastructure leverage.

The business model centers on open access publishing of peer-reviewed articles supplemented by themed Special Issues (e.g., precision oncology, targeted nanotherapeutics). The customer base spans academic and research institutions, clinical and medical professionals, and biotech and pharmaceutical industry researchers — a horizontal, distributed set with no disclosed enterprise anchor accounts. Headcount is reported at 11-50 employees. Pricing details, including any article processing charges, are not publicly disclosed in the source material, and no funding events, M&A activity, or financial metrics were found.

Short descriptiontext

Theranostics is a peer-reviewed open access scientific journal (Impact Factor 14.9) covering in vitro diagnostics, molecular imaging, therapeutics, biosensors, and translational medicine, published by Ivyspring International Publisher and indexed by SCI, MEDLINE, PubMed Central, and Europe PMC.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
peer-reviewed scientific journal, open access publishing, biomedical research publication, molecular imaging research, translational medicine journal
Industry2 codes
1Medical, Clinical & Biomedical Scholarly Publishing
CodeEDAGAFABPrimaryYes
2Medical & Clinical Reference (Physicians, Nursing, Allied Health)
CodeEDAGAGAAPrimaryNo
NAICS code1 code
  • Periodical Publishers513120
Product category
Scientific Journal Publishing
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Theranostics is a peer-reviewed open access scientific journal that publishes original research articles, reviews, and themed special issues across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher under Creative Commons licensing, with an Impact Factor of 14.9, and is indexed in SCI, MEDLINE, PubMed Central, and Europe PMC for global readership.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Impact Factor: 14.9
+1 more record
Product overview1 text field

Theranostics is a single academic journal published by Ivyspring International Publisher. The platform offers one core product: the Theranostics Journal, an international peer-reviewed open access publication with an Impact Factor of 14.9. The journal covers biomedical research including in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. Special themed issues provide focused collections on specific research topics. No SaaS platform, modules, or add-on products are offered.

Product and service2 records
1Theranostics Journal
CategoryScientific Journal
Description

International peer-reviewed open access journal publishing innovative research across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine, with an Impact Factor of 14.9 and indexing in SCI, MEDLINE, PubMed Central, and Europe PMC.

2Theranostics Special Issues
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Theranostics

Scientific Journal Publishingthno.org

Theranostics is a peer-reviewed open access scientific journal (Impact Factor 14.9) covering in vitro diagnostics, molecular imaging, therapeutics, biosensors, and translational medicine, published by Ivyspring International Publisher and indexed by SCI, MEDLINE, PubMed Central, and Europe PMC.

What Theranostics does

Theranostics is a peer-reviewed open access scientific journal publishing original research in in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher, a private entity domiciled in New South Wales, Australia, and reports an Impact Factor of 14.9. Full texts are archived in PubMed Central and Europe PMC, and the journal is indexed by the Science Citation Index (SCI) and MEDLINE, ensuring broad global discoverability and full compliance with the NIH Public Access Requirement. New articles are distributed under a Creative Commons Attribution 4.0 International (CC-BY) license, with earlier articles under CC-BY-NC 4.0.

The editorial platform is led by Founding Editor-in-Chief Prof. Xiaoyuan (Shawn) Chen (H-index 219, approximately 180,000 citations; Clarivate Highly Cited Researcher for eight consecutive years), whose scientific standing in nuclear medicine, molecular imaging, and nanomedicine anchors the journal's submission quality and reputation. The publisher operates a broader journal portfolio (Nanotheranostics, International Journal of Biological Sciences, International Journal of Medical Sciences, Journal of Cancer) that creates cross-referencing and shared infrastructure leverage.

The business model centers on open access publishing of peer-reviewed articles supplemented by themed Special Issues (e.g., precision oncology, targeted nanotherapeutics). The customer base spans academic and research institutions, clinical and medical professionals, and biotech and pharmaceutical industry researchers — a horizontal, distributed set with no disclosed enterprise anchor accounts. Headcount is reported at 11-50 employees. Pricing details, including any article processing charges, are not publicly disclosed in the source material, and no funding events, M&A activity, or financial metrics were found.

Theranostics firmographics

Firmographics
Name
Theranostics
Legal name
Ivyspring International Publisher
Website
https://thno.org
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Theranostics is a peer-reviewed open access scientific journal (Impact Factor 14.9) covering in vitro diagnostics, molecular imaging, therapeutics, biosensors, and translational medicine, published by Ivyspring International Publisher and indexed by SCI, MEDLINE, PubMed Central, and Europe PMC.
Ownership category
akta.pro rank

Theranostics industry classification

Industry
Product category
Scientific Journal Publishing
NAICS
Periodical Publishers (513120)
akta.pro primary industry
Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)
akta.pro secondary industry
Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

  • Peer-reviewed scientific journal
  • Open access publishing
  • Biomedical research publication
  • Molecular imaging research
  • Translational medicine journal

Where Theranostics is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Markets served

Theranostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels4 records

Marketing channels3 records

Theranostics product offering

Product offering

Core offering

Theranostics is a peer-reviewed open access scientific journal that publishes original research articles, reviews, and themed special issues across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher under Creative Commons licensing, with an Impact Factor of 14.9, and is indexed in SCI, MEDLINE, PubMed Central, and Europe PMC for global readership.

Product overview

Theranostics is a single academic journal published by Ivyspring International Publisher. The platform offers one core product: the Theranostics Journal, an international peer-reviewed open access publication with an Impact Factor of 14.9. The journal covers biomedical research including in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. Special themed issues provide focused collections on specific research topics. No SaaS platform, modules, or add-on products are offered.

Differentiator

Problem solved

Functional benefit

Products and services

  • Theranostics Journal International peer-reviewed open access journal publishing innovative research across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine, with an Impact Factor of 14.9 and indexing in SCI, MEDLINE, PubMed Central, and Europe PMC.
  • Theranostics Special Issues

Quantifiable outcome

  • Impact Factor: 14.9
  • +1 more outcomes

Companies that use Theranostics

Customer profile

Segments3 records

Ideal customer profiles3 records

Theranostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Theranostics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights3 records

Theranostics competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Theranostics social profiles

Digital presence

Theranostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Theranostics leadership team

Management profile

Number of profiles

Profiles1 record

Theranostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Theranostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Theranostics

What does Theranostics do?

Theranostics is a peer-reviewed open access scientific journal that publishes original research articles, reviews, and themed special issues across in vitro diagnostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology, and translational medicine. The journal is published by Ivyspring International Publisher under Creative Commons licensing, with an Impact Factor of 14.9, and is indexed in SCI, MEDLINE, PubMed Central, and Europe PMC for global readership.

Is Theranostics a public or private company?

Theranostics is a private company. It is classified as unknown and is currently operating.

When was Theranostics founded?

Theranostics was founded in 2011. It employs 11 to 50 people.

Where is Theranostics based?

Theranostics is headquartered in Sydney, Australia, in the Oceania region.

Does Theranostics have an API?

No public API is recorded for Theranostics.

What industry is Theranostics in?

Theranostics's product category is Scientific Journal Publishing. Its primary akta.pro industry code is EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing, with a secondary code of EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health). Its NAICS code is 513120.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales